Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotterdam Early Arthritis Cohort treatment study
NL-OMON27362Recruiting
- Start
- Jun 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methotrexate, 5-aminosalicylic acid + sulphasalazine, hydroxychloroquine and corticosteroids in rheumatoid arthritis (RA), autoimmune arthritis and chronic arthritis (4 arms). Started Jun 2007; status: recruiting.
02
Drugs
methotrexate5-aminosalicylic acid + sulphasalazinehydroxychloroquinecorticosteroids
03
Conditions
rheumatoid arthritis (RA)autoimmune arthritischronic arthritis
Beyond the preview
Go deeper on NL-OMON27362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27362.